[研究报告] 2022年结直肠癌治疗市场价值为188.10亿美元，预计到2030年将达到239.78亿美元。预计2022-2030年的复合年增长率为3.1%。
市场洞察和分析师观点：
市场规模不断增长，归因于结直肠癌病例数量的增加以及用于治疗结直肠癌的靶向治疗和免疫治疗的批准增加。此外，公司为保持市场竞争力而采取的战略举措也推动了市场增长。个性化药物的大幅增加，以满足客户对结直肠癌治疗的需求，可能会在预测期内带来新的结直肠癌治疗市场趋势。
增长动力和挑战：
结直肠癌是一种发生在结肠或直肠组织的恶性肿瘤。水果和蔬菜摄入量低、吸烟成瘾、久坐不动、肥胖、加工肉类摄入量高以及过量饮酒等生活方式因素导致结直肠癌病例的增长。它是美国每年诊断出的第三大常见癌症类型（皮肤癌除外）。2023 年，世界卫生组织 (WHO) 表示，结直肠癌是全球第三大常见癌症，也是全球第二大癌症相关死亡原因。根据同一来源，全球诊断出的总病例中约有 10% 是结直肠癌病例。根据美国癌症协会的估计，2023 年美国登记了约 106,000 例新的结肠癌病例和约 46,000 例新的直肠癌病例。
根据欧洲癌症信息系统提供的数据，结直肠癌约占 2020 年诊断出的所有新癌症的 12.7%，2020 年欧盟 27 国中约有 12.4% 的死亡是由结直肠癌引起的。由于发病率高，结直肠癌是仅次于乳腺癌的第二大常见癌症，也是仅次于肺癌的第二大癌症相关死亡原因。根据国际癌症研究机构和 GLOBOCAN 的数据，2020 年亚洲报告了约 100 万例新结直肠癌病例。与亚太地区的其他国家相比，日本、马来西亚、中国、新加坡、土耳其和韩国的发病率较高。此外，到 2040 年，全球结直肠癌负担预计将增加 72%，达到 300 多万新病例，对人类健康构成严重威胁。因此，结直肠癌发病率的上升推动了结直肠癌治疗市场的增长。
定制此报告以满足您的需求
您可以免费定制任何报告，包括本报告的部分内容、国家级分析、Excel 数据包，以及为初创企业和大学提供优惠和折扣
结直肠癌治疗市场：
- 获取此报告的关键市场趋势。这个免费样品将包括数据分析，从市场趋势到估计和预测。
报告细分和范围：
结直肠癌治疗市场分析考虑了以下细分市场：治疗类型、年龄组、最终用户和地理位置。按治疗类型，结直肠癌治疗市场分为手术、化疗、靶向治疗、免疫治疗和其他。根据年龄组，市场分为 49 岁以下、50-64 岁和 65 岁以上。按最终用户，市场分为医院、专科诊所、家庭护理和其他。结直肠癌治疗市场报告的范围包括北美（美国、加拿大和墨西哥）、欧洲（西班牙、英国、德国、法国、意大利和欧洲其他地区）、亚太地区（韩国、中国、日本、印度、澳大利亚和亚太其他地区）、中东和非洲（南非、沙特阿拉伯、阿联酋和中东和非洲其他地区）以及南美洲和中美洲（巴西、阿根廷和南美洲和中美洲其他地区）。
节段分析：
按照治疗类型，结直肠癌治疗市场分为手术、化疗、靶向治疗、免疫治疗等。2022 年，手术占据了结直肠癌治疗市场的最大份额，预计在 2022-2030 年期间将录得最高复合年增长率。手术被认为是结直肠癌所有阶段最常见的治疗方法。如果在早期诊断出癌症，则进行手术切除肿瘤。
根据年龄组，市场细分为 49 岁以下、50-64 岁和 65 岁以上。2022 年，65 岁以上人群占据结直肠癌治疗市场的最大份额，预计在 2022-2030 年期间将录得最高复合年增长率。根据美国癌症协会的报告，估计美国诊断出的新病例中有一半以上年龄在 65 岁以上，所有结直肠癌死亡病例中有三分之二以上发生在 65 岁以上的人群中。
根据最终用户，市场分为医院、专科诊所、家庭护理和其他。医院部门的结肠直肠癌治疗市场规模可能会在 2022-2030 年期间激增。
区域分析：
北美是全球结直肠癌治疗市场增长的最大贡献者。预计亚太地区在 2022-2030 年期间的市场复合年增长率最高。由于结直肠癌数量不断增加、技术进步不断加快、50 岁以下人群结直肠癌患病率高以及主要市场参与者参与新产品和现有产品的开发，北美在 2022 年占据了全球市场的最大份额。在北美，美国在 2022 年占据了最大的市场份额。
行业发展和未来机遇：
结直肠癌治疗市场预测是根据各种二手和一手研究结果（如主要公司出版物、协会数据和数据库）估算的。结直肠癌治疗市场主要参与者的策略如下：
- 2023 年 11 月，武田制药宣布其口服靶向治疗药物 FRUZAQLA（呋喹替尼）已获得美国食品药品监督管理局 (FDA) 批准，用于治疗患有转移性结直肠癌 (mCRC) 的成年人。FRUZAQLA 是美国之前批准用于治疗 mCRC 的首个也是唯一一个选择性抑制所有三种 VEGF 受体激酶的药物，无论生物标志物状态如何。
- 2023年8月，大鹏制药宣布，美国FDA批准LONSURF（三氟尿苷/替吡嘧啶）作为单药或与贝伐单抗联合用于治疗转移性结直肠癌成年患者。这些患者之前接受过以奥沙利铂、氟嘧啶和伊立替康为基础的化疗，这是一种抗VEGF生物疗法。
结直肠癌治疗市场区域洞察
Insight Partners 的分析师已详细解释了预测期内影响结直肠癌治疗市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的结直肠癌治疗市场细分和地理位置。
- 获取结直肠癌治疗市场的区域特定数据
结直肠癌治疗市场报告范围
| 报告属性 | 细节 |
|---|---|
| 2022 年市场规模 | 188.10亿美元 |
| 2030 年的市场规模 | 239.78亿美元 |
| 全球复合年增长率（2022 - 2030 年） | 3.1％ |
| 史料 | 2020-2022 |
| 预测期 | 2022-2030 |
| 涵盖的领域 | 按治疗类型
|
| 覆盖地区和国家 | 北美
|
| 市场领导者和主要公司简介 |
|
结直肠癌治疗市场参与者密度：了解其对业务动态的影响
结直肠癌治疗市场正在快速增长，这得益于终端用户需求的不断增长，而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加，企业正在扩大其产品范围，进行创新以满足消费者的需求，并利用新兴趋势，从而进一步推动市场增长。
市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中，相对于其规模或总市场价值，有多少竞争对手（市场参与者）存在。
在结直肠癌治疗市场运营的主要公司有：
- 基因泰克公司
- 礼来公司
- 辉瑞公司
- 武田制药
- 百时美施贵宝
免责声明：上面列出的公司没有按照任何特定顺序排列。
- 了解结直肠癌治疗市场顶级关键参与者概况
竞争格局和重点公司：
基因泰克公司、礼来公司、辉瑞公司、武田制药、百时美施贵宝、默克公司、拜耳公司、再生元制药公司、诺华公司和益普生生物制药公司是结直肠癌治疗市场报告中介绍的知名企业。此外，研究还研究和分析了其他几家企业，以全面了解市场及其生态系统。这些公司专注于地域扩张和新产品发布，以满足全球消费者日益增长的需求，并增加其专业产品组合的产品范围。他们的全球影响力使他们能够服务于庞大的客户群，从而促进市场扩张。
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The colorectal cancer treatment market majorly consists of the players such Genentech Inc, Eli Lilly and Company, Pfizer Inc, Takeda Pharmaceuticals, Bristol Myers Squibb, Merck, Bayer AG, Regeneron Pharmaceuticals Inc, Novartis AG, and Ipsen Biopharmaceuticals Inc.
Based on geography, the colorectal cancer treatment market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). North America is the largest contributor to the growth of the global colorectal cancer treatment market. Asia Pacific is expected to register the highest CAGR in the colorectal cancer treatment market during 2022–2030.
Colorectal cancer often begins as a growth called a polyp inside the colon or rectum. Colorectal cancer happens when there are changes in genetic material (DNA). These changes are also called mutations or variants. Often, the genetic changes that lead to colorectal cancer happen during lifetime and the exact cause is unknown. Colorectal cancer treatment includes surgery, chemotherapy, radiation therapy, targeted therapy, immunotherapy, cryosurgery, and radiofrequency ablation.
The growing number of colorectal cancer cases and the subsequent increase in product launches are factors predominantly driving the colorectal cancer treatment market size. However, the high cost associated with colorectal cancer treatment in developing countries hinders the market growth.
The colorectal cancer treatment market, by treatment type, is segmented into surgery, chemotherapy, targeted therapy, immunotherapy, and others. In 2022, the surgery segment held the largest colorectal cancer treatment market share and is expected to record the highest CAGR during 2022–2030.
Based on age group, the market is segmented into below 49 years, 50–64 years, and above 65 years. In 2022, the above 65 years segment held the largest colorectal cancer treatment market share and is projected to record the highest CAGR during 2022–2030.
Based on end user, the market is divided into hospitals, specialty clinics, home care, and others. The colorectal cancer treatment market size for the hospital segment is likely to surge during 2022–2030.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - Colorectal Cancer Treatment Market
- Genentech Inc
- Eli Lilly and Company
- Pfizer Inc
- Takeda Pharmaceuticals
- Bristol Myers Squibb
- Merck
- Bayer AG
- Regeneron Pharmaceuticals Inc
- Novartis AG
- Ipsen Biopharmaceuticals
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For